Abstract
The new benzoxazole derivative nataxazole was isolated from Streptomyces sp. (strain Tü 6176). Nataxazole is related in structure to the potent antitumor compounds UK-1 and AJI9561 and showed similar strong growth inhibitory activity against various human tumor cell lines.
Similar content being viewed by others
Article PDF
References
Fiedler H-P, Dieter A, Gulder TAM, Kajahn I, Hamm A, Brown R, Jones AL, Goodfellow M, Müller WEG, Bringmann G . Genoketides A1 and A2, new octaketides and biosynthetic intermediates of chrysophanol produced by Streptomyces sp. AK 671. J Antibiot 61: 464–473 ( 2008)
Fiedler H-P . Biosynthetic capacities of actinomycetes. 1. Screening for secondary metabolites by HPLC and UV-Visible absorbance spectral libraries. Nat Prod Lett 2: 119–128 ( 1993)
Staneck JL, Roberts GD . Simplified approach to the identification of aerobic actinomycetes by thin layer chromatography. Appl Microbiol 28: 226–231 ( 1974)
Williams ST, Goodfellow M, Alderson G . Genus Streptomyces Waksman and Henrici 1943, 339AL. In Bergey's Manual of Systematic Bacteriology, Vol. 4. Ed., Williams ST et al., pp. 2452–2492, Williams & Wilkins, Baltimore ( 1989)
Ueki M, Shibata K, Taniguchi M . UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. IV. Antifungal action of methyl UK-1. J Antibiot 46: 1089–1094 ( 1998)
Sato S, Kajiura T, Noguchi M, Takehana K, Kobayashi T, Tsuji T . AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiot 54: 102–104 ( 2001)
Grever MR, Shepartz SA, Chabner BA . The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 19: 622–638 ( 1992)
Reynolds MB, DeLuca MR, Kerwin SM . The novel bis(benzoxazole) cytotoxic natural product UK-1 is a magnesium ion-dependent DNA binding agent and inhibitor of human topoisomerase II. Bioorg Chem 27: 326–337 ( 1999)
Kaufmann WK . Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med 217: 327–334 ( 1998)
Author information
Authors and Affiliations
Corresponding authors
Additional information
†Art. No. 47 in ‘Biosynthetic Capacities of Actinomycetes’. Art. No. 46: see ref. 1
Rights and permissions
About this article
Cite this article
Sommer, P., Almeida, R., Schneider, K. et al. Nataxazole, a New Benzoxazole Derivative with Antitumor Activity Produced by Streptomyces sp. Tü 6176†. J Antibiot 61, 683–686 (2008). https://doi.org/10.1038/ja.2008.97
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2008.97
Keywords
This article is cited by
-
Targeting disease with benzoxazoles: a comprehensive review of recent developments
Medicinal Chemistry Research (2024)
-
Biological activity of 3-(2-benzoxazol-5-yl)alanine derivatives
Amino Acids (2021)
-
Anticancer activity of benzoxazole derivative (2015 onwards): a review
Future Journal of Pharmaceutical Sciences (2020)
-
Exploring the biocombinatorial potential of benzoxazoles: generation of novel caboxamycin derivatives
Microbial Cell Factories (2017)
-
Chemical Interaction among Termite-Associated Microbes
Journal of Chemical Ecology (2017)